Pegulicianine: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

18 March 2025

  • curprev 19:5019:50, 18 March 2025 Alara E. Dagsali talk contribs 17,295 bytes +96 No edit summary
  • curprev 19:4819:48, 18 March 2025 Alara E. Dagsali talk contribs 17,199 bytes +17,199 Created page with "{{DrugProjectFormSinglePage |authorTag=User:AED |genericName=pegulicianine |aOrAn=a |drugClass=diagnostic imaging agent |indicationType=diagnosis |indication=LUMISIGHT is indicated for fluorescence imaging in adults with breast cancer as an adjunct for the intraoperative detection of cancerous tissue within the resection cavity following removal of the primary specimen during lumpectomy surgery. |hasBlackBoxWarning=Yes |adverseReactions=*Anaphylaxis and Other Serious Hyp..."
Retrieved from "https://www.wikidoc.org/index.php/Pegulicianine"